ApoB and ApoA1 Best Predict Heart Attack: How To Get Tested

🎧 ▶️ Press play below to listen.

Introduction

Heart disease is the number one cause of death in the United States. Millions of Americans get their cholesterol checked every year, but the standard blood test — which reports total cholesterol, LDL-C, HDL-C, and triglycerides — doesn’t always give the full picture of heart attack risk.

In our previous article, ApoB vs LDL Cholesterol: Which Predicts Heart Attacks Better, we explained why ApoB and the ApoB/ApoA1 ratio are better predictors of heart attacks than LDL-C or HDL-C alone.

This article is about the practical side: how ApoB and ApoA1 testing works, where to get it, and why it matters for your health.

---

Section I. Why ApoB and ApoA1 Testing Matters

ApoB (Apolipoprotein B)

• ApoB is a protein found on every “bad” cholesterol particle: LDL, VLDL, IDL, and Lp(a).
• Each particle carries one ApoB protein, so measuring ApoB tells you how many harmful particles are circulating.
• More ApoB = more particles that can sneak into artery walls and cause plaque buildup.

ApoA1 (Apolipoprotein A1)

• ApoA1 is the main protein on HDL, the “good” cholesterol.
• It represents the protective side of the equation, since HDL particles help clear cholesterol out of arteries and fight inflammation.

ApoB/ApoA1 Ratio: The Balance of Risk and Protection

• The ratio compares bullets (ApoB particles) to shields (ApoA1 particles).
• A high ratio means more bullets than shields → higher heart attack risk.
• A low ratio means more shields than bullets → lower heart attack risk.
• Large international studies show this ratio is often a better predictor of heart attacks than LDL-C, HDL-C, or triglycerides alone.

Section II. What the Guidelines Say

Doctors and researchers worldwide agree that ApoB is a stronger predictor of cardiovascular risk than LDL-C alone. Here’s how the major guidelines compare:

• European Society of Cardiology (ESC/EAS 2019):
  • Recommends ApoB (or non-HDL-C) as the primary target in patients with diabetes, metabolic syndrome, or high triglycerides.
• American College of Cardiology/AHA (2018 Cholesterol Guidelines):
  • Lists ApoB as a “risk enhancer.”
  • Most useful when LDL-C seems out of line with the clinical picture — for example, a lean person on a keto diet with high LDL-C but low triglycerides and high HDL-C.
• Canadian Guidelines (2012, reaffirmed 2021):
  • Go a step further: ApoB is a standard target, not an optional one.
  • Thresholds: ≥80–100 mg/dL, depending on your risk profile.
• ApoA1:
  • Not used much as a stand-alone test.
  • Its primary role is in calculating the ApoB/ApoA1 ratio, which integrates both risk (ApoB) and protection (ApoA1).

👉 Takeaway: Global guidelines are moving toward ApoB as the accurate measure of atherogenic risk. The U.S. is more cautious, but even here, experts acknowledge its value — especially when LDL-C alone doesn’t make sense.

---

Section III. Where to Get ApoB and ApoA1

• Not part of the standard lipid panel.
  • Your routine blood test (total cholesterol, LDL-C, HDL-C, triglycerides) does not include ApoB or ApoA1.
• Available in most U.S. labs:
  • Quest Diagnostics
  • LabCorp
  • Hospital and specialty lipid labs
• Who usually orders it?
  • Lipidologists (cholesterol specialists)
  • Preventive cardiologists (doctors focused on stopping heart disease before it starts)
  • Endocrinologists (especially for diabetic patients)
  • Some primary care doctors who follow advanced guidelines
• Insurance and cost:
  • Most U.S. insurance plans cover ApoB if ordered with the right ICD-10 code (e.g., hyperlipidemia, cardiovascular risk).
  • ApoA1 is often covered if ordered together.
  • The out-of-pocket cost is usually $20–50 per test — an affordable expense if you need to pay yourself.

👉 Tip for patients: If you want ApoB or ApoA1 checked, you often have to ask your doctor directly.

Section IV. The Current Reality in the U.S.

Although research and international guidelines strongly support the use of ApoB and the ApoB/ApoA1 ratio, these tests are still not routinely performed in most U.S. doctors’ offices.

• Most people only get the standard lipid panel (total cholesterol, LDL-C, HDL-C, triglycerides).
• Non-HDL-C (total cholesterol – HDL-C) is sometimes used as a “poor man’s ApoB,” but it’s not as precise.
• ApoB and ApoA1 are becoming more common as doctors adopt advanced lipid testing and “precision medicine,” but they’re far from universal.
• This means that if you want the test, you’ll usually have to ask for it directly.

👉 That leads to the next question most patients have: “If I ask for ApoB and ApoA1, will my insurance cover it?”

---

Section V. Insurance and Cost

To ensure insurance coverage for ApoB and ApoA1, it’s essential to establish “medical necessity.” Many insurers don’t cover these tests for routine screening, and some consider them experimental or unproven for general cardiovascular risk. But there are ways to improve your chances of coverage:

Step 1. Consult Your Doctor

Work with your doctor and make sure they document a valid reason. Coverage is more likely in situations such as:

• Strong family history: Premature heart disease, stroke, or related conditions.
• Multiple risk factors: Diabetes, metabolic syndrome, or high blood pressure.
• Response to treatment: Monitoring cholesterol therapy effectiveness (like statins).
• High-risk individuals: People with hypercholesterolemia, especially if LDL-C goals are met but risk remains high.

Step 2. Check Your Insurance Policy

• Review your plan documents: Look for “laboratory services” or “cardiovascular disease risk tests.”
• Contact your insurer directly: Ask specific questions:
  • What are the coverage criteria for ApoB and ApoA1 tests?
  • Is prior authorization required?
  • Do you need a specific diagnostic code?
  • What’s the out-of-pocket cost if not covered?

Step 3. Secure Proper Documentation and Coding

• Doctor’s order: Should include CPT codes for ApoB and ApoA1.
• Diagnostic code (ICD-10): Needs to clearly show risk (e.g., family history of hyperlipidemia, not just “screening”).
• Examples of accepted codes:
  • E78.5 – Hyperlipidemia, unspecified
  • E78.2 – Mixed hyperlipidemia
  • Z13.6 – Screening for cardiovascular disorders
  • I25.10 – Atherosclerotic heart disease, unspecified

Step 4. If Denied, Explore Options

• Appeal the decision: Submit your doctor’s documentation of medical necessity.
• Use HSA/FSA funds: You can pay with pre-tax dollars.
• Negotiate a self-pay rate: Ask the lab about discounted “self-pay” prices.
• Explore discount programs: Online services like MDsave often provide lower prices.

---

👉 Bottom line: ApoB and ApoA1 are not always covered for routine checks, but with proper documentation and the right codes, most insurers will pay. And even if not covered, the out-of-pocket price ($20–50) is affordable compared to other heart health tests.

Conclusion and What’s Next

ApoB and ApoA1 testing give a far clearer picture of your heart attack risk than the standard cholesterol panel alone. Together, they show the balance between harmful particles and protective ones — the “bullets versus shields.”

Although these tests aren’t yet routine in most U.S. clinics, they’re widely available, relatively inexpensive, and recommended by international guidelines. If you want the best insight into your cardiovascular risk, it’s worth asking your doctor to order them.

---

Coming Soon

In our next article, we’ll explain how to interpret your ApoB and ApoA1 results so you’ll know what the numbers mean for your long-term health.

We’ll also explore another vital question:

How do we predict heart attack risk in people who are not diabetic, not overweight, and living a healthy lifestyle — but who may still be prediabetic?

Stay tuned to learn how risk can be hidden even in those who look “healthy” on the outside.

Don’t Get Sick!

💡 Support This Work

Creating well-researched articles, maintaining this website, and keeping the information free takes time and resources.
If you found this article helpful, please consider donating to support the mission of empowering people to live healthier, longer lives, without relying on medications.

🙏 Every contribution, big or small, truly makes a difference. Thank you for your support!

Follow me on Facebook, Gab, Twitter (formerly known as X), and Telegram.

Related:

1. Live Strong, Die Later: Outsmart Hypertension With Action
2. 8 Risk Factors to Control To Lower Hypertension Death Risk
3. End Hypertension Now With These Heart-Saving Superfoods
4. Escape Hypertension Now: The Shocking Truth About Exercise Vs. Pills
5. Can A Blood Pressure Drug Increase Lung Cancer Risk? What You Need to Know About ACE Inhibitors
6. Flaxseeds Naturally Lower Blood Pressure – Proven Science For Heart Health
7. New Study: Vitamin D Fights High Blood Pressure
8. Aerobic, Resistance and Combined Exercise Lower High Blood Pressure
9. Sugar Increases Blood Pressure, Weight, Worsens Diabetes and COVID-19 Outcomes
10. Foods High in Tyramine: Managing Migraines and Blood Pressure
11. 3 Reasons Why Your Blood Pressure is High and What to Do About Them
12. Using the Circadian Rhythm for More Effective Blood Pressure Control
13. Cholesterol and Blood Sugar: The Strong Link
14. ApoB vs LDL Cholesterol: Which Predicts Heart Attacks Better
15. Heart Attack Risk? Use The Framingham Risk Calculator And Lower It Now!
16. Discover Your Cardiac Age with This Free Calculator
17. Heart Rate Recovery Reveals Hidden Secrets About Your Heart
18. Drink Coffee At This Time To Slash Heart Attack Risk
19. The FODMAP Trap That Mimics Heart Attacks During Exercise
20. The Hidden Link Between High Blood Sugar and Heart Attacks
21. Strep From the Mouth and Blood and Sudden Cardiac Death — What You Need to Know
22. Lithium’s Hidden Power: Unlocking Protection Against Cardiovascular Disease
23. How Reduced Blood Sugar Lowers BP And Cardiovascular Risks

References:

1. American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. (2019). 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol. Journal of the American College of Cardiology, 73(24), e285–e350. https://doi.org/10.1016/j.jacc.2018.11.003
2. European Society of Cardiology (ESC) & European Atherosclerosis Society (EAS). (2019). ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk. European Heart Journal, 41(1), 111–188. https://doi.org/10.1093/eurheartj/ehz455
3. Sniderman, A. D., Toth, P. P., Thanassoulis, G., Furberg, C. D., & Couture, P. (2019). An evidence-based analysis of ApoB and non-HDL-C as risk markers for cardiovascular disease. Journal of the American College of Cardiology, 73(24), 3157–3173. https://doi.org/10.1016/j.jacc.2019.04.012
4. Walldius, G., & Jungner, I. (2006). The ApoB/ApoA-I ratio: A strong, new risk factor for cardiovascular disease and a target for lipid-lowering therapy—A review of the evidence. Journal of Internal Medicine, 259(5), 493–519. https://doi.org/10.1111/j.1365-2796.2006.01643.x
5. Yusuf, S., Hawken, S., Ounpuu, S., Dans, T., Avezum, A., Lanas, F., … INTERHEART Study Investigators. (2004). Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): Case-control study. The Lancet, 364(9438), 937–952. https://doi.org/10.1016/S0140-6736(04)17018-9

© 2018 – 2025 Asclepiades Medicine, LLC. All Rights Reserved
DrJesseSantiano.com does not provide medical advice, diagnosis, or treatment

As an Amazon Associate, I earn from qualifying purchases